• Sarepta Therapeutics' (SRPT) Overweight Rating Reiterated at Cantor Fitzgerald

    المصدر: Buzz FX / 19 مارس 2025 09:46:18   America/New_York


    Sarepta Therapeutics' (SRPT) Overweight Rating Reiterated at Cantor Fitzgerald Written by MarketBeat March 19, 2025 Share Link copied to clipboard. Remove Ads Sarepta Therapeutics ( NASDAQ:SRPT - Get Free Report ) 's stock had its "overweig
    Read more...
شارك على،